Skip to main content
Clinical Trials/JPRN-UMIN000023416
JPRN-UMIN000023416
Not Yet Recruiting
Phase 2

Prospective Study of Concurrent Chemoradiotherapy with S-1 and hypofractionated radiotherapy for outpatients with early glottic squamous cell carcinomas - Prospective Study of Concurrent Chemoradiotherapy with S-1 and hypofractionated radiotherapy for outpatients with early glottic squamous cell carcinomas

agoya University Graduate School of Medicine, Department of Radiology0 sites40 target enrollmentAugust 31, 2016

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
agoya University Graduate School of Medicine, Department of Radiology
Enrollment
40
Status
Not Yet Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 31, 2016
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
agoya University Graduate School of Medicine, Department of Radiology

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • (1\) unable to take oral S\-1; (2\) with a history of severe allergy; (3\) severe clinical infection; (4\) with active double cancer including simultaneous cancer or metachronous cancer within 5 years, except for in situ or intramucosal carcinoma; (5\) being pregnant or breast feeding; (6\) with mental disease interfering participating the trial; (7\) with severe bone marrow dysfunction; (8\) with the history of kidney disease, such as getting dialysis; (9\) with the history of severe liver disease; (10\)with the history of severe lung disease, such as interstitial pneumonia of pulmonary fibrosis; (11\) with the history of collagen disease; (12\) with uncontrolled diabetes mellitus or insulin\-dependent diabetes mellitus; (13\) with uncontrolled hypertension; (14\) cardiovascular diseases with clinical significance, such as heart failure, history of myocardial infarction or angina in the past half year; (15\) taking drugs as follows; other pyrimidine compound\- anticancer drug or flucytosine ; (16\) jugged as inadequate case by doctor in charge.

Outcomes

Primary Outcomes

Not specified

Similar Trials